Luminex Corp (LMNX)-Pharmaceuticals & Healthcare-Deals and Alliances Profile
July 2017
30
About the Report
About the Report
Summary
Luminex Corp (Luminex) is a medical devices company which develops, manufactures and markets proprietary biological testing technologies. The company offers wide range of products including instruments, assays, reagents and accessories, software and replacement parts. Its proprietary technologies consist of xMAP technology, xTAG and MultiCode technology. Luminex offers its products to various markets such as clinical diagnostics; pharmaceutical drug discovery; biomedical research including personalized medicine, genomic and proteomic research, biodefense research and food safety. The company sells its products through direct sales channel and strategic distribution partners in North America, Europe and Asia-Pacific. Luminex is headquartered in Texas, the US.
Luminex Corp (LMNX)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
Business Description-A brief description of the company's operations.
Key Employees-A list of the key executives of the company.
Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
Key Competitors-A list of the key competitors of the company.
Key Recent Developments-A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Products
Products
Luminex Corp, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.
Table of Contents
Table of Contents
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Luminex Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Luminex Corp, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Luminex Corp, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Luminex Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Luminex Corp, Medical Devices Deals, 2011 to YTD 2017 9
Luminex Corp, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Luminex Corp, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Luminex Extends Distribution Agreement With EMD Millipore 11
Equity Offering 12
Nanosphere Raises USD10 Million in Public Offering of Shares 12
Nanosphere to Raise USD4.4 Million in Private Placement of Convertible Preferred Stock 13
Nanosphere Raises USD4.4 Million in Private Placement of Series A Convertible Preferred Stock 14
Acquisition 15
Luminex Acquires Nanosphere in Tender Offer 15
Luminex Corp-Key Competitors 18
Key Employees 19
Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Recent Developments 23
Financial Announcements 23
May 01, 2017: Luminex Reports Record First Quarter 2017 Financial Results; Raises 2017 Financial Guidance 23
Feb 06, 2017: Luminex Reports Fourth Quarter And Full Year 2016 Results 24
Jan 09, 2017: Luminex Announces Preliminary Revenue for Fourth Quarter 2016 and Issues 2017 Revenue Guidance 25
Oct 31, 2016: Luminex Reports Third Quarter 2016 Results; Raises Full Year Guidance 26
Jul 28, 2016: Luminex Reports Second Quarter 2016 Results 27
May 02, 2016: Luminex Reports First Quarter 2016 Results 28
Feb 01, 2016: Luminex Reports Fourth Quarter And Full Year 2015 Results 29
Appendix 30
Methodology 30
About GlobalData 30
Contact Us 30
Disclaimer 30
List of Figure
List of Figures
Luminex Corp, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1
Luminex Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1
Luminex Corp, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1
Luminex Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1
Luminex Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Luminex Corp, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6
Luminex Corp, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Luminex Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Luminex Corp, Medical Devices Deals, 2011 to YTD 2017 9
List of Table
List of Tables
Luminex Corp, Pharmaceuticals & Healthcare, Key Facts, 2016 1
Luminex Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Luminex Corp, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Luminex Corp, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Luminex Corp, Deals By Therapy Area, 2011 to YTD 2017 8
Luminex Corp, Medical Devices Deals, 2011 to YTD 2017 9
Luminex Corp, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Luminex Extends Distribution Agreement With EMD Millipore 11
Nanosphere Raises USD10 Million in Public Offering of Shares 12
Nanosphere to Raise USD4.4 Million in Private Placement of Convertible Preferred Stock 13
Nanosphere Raises USD4.4 Million in Private Placement of Series A Convertible Preferred Stock 14
Luminex Acquires Nanosphere in Tender Offer 15
Luminex Corp, Key Competitors 18
Luminex Corp, Key Employees 19
Luminex Corp, Other Locations 21
Luminex Corp, Subsidiaries 21
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.